These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11157033)

  • 1. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.
    Eisbruch A; Shewach DS; Bradford CR; Littles JF; Teknos TN; Chepeha DB; Marentette LJ; Terrell JE; Hogikyan ND; Dawson LA; Urba S; Wolf GT; Lawrence TS
    J Clin Oncol; 2001 Feb; 19(3):792-9. PubMed ID: 11157033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent chemoradiation with low-dose and long-duration weekly infusion of gemcitabine in unresectable squamous cell carcinoma of head and neck (SCCHN).
    Ahmad F; Akram M; Khan M
    J Cancer Res Ther; 2024 Apr; 20(3):827-831. PubMed ID: 39023590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine).
    Fields MT; Eisbruch A; Normolle D; Orfali A; Davis MA; Pu AT; Lawrence TS
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):785-91. PubMed ID: 10837965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trial.
    De Santis M; Bachner M; Cerveny M; Kametriser G; Steininger T; Königsberg R; Schratter-Sehn A; Sedlmayer F; Dittrich C
    Ann Oncol; 2014 Sep; 25(9):1789-1794. PubMed ID: 24936582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study.
    Mohiuddin M; Kudrimoti M; Regine WF; McGrath PC; Hanna N; John W
    Cancer J; 2002; 8(3):255-62. PubMed ID: 12074325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Ali EM; Abdelraheem AG
    Head Neck Oncol; 2011 Nov; 3():48. PubMed ID: 22085617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with locally advanced pancreatic cancer.
    Ikeda M; Okada S; Tokuuye K; Ueno H; Okusaka T
    Br J Cancer; 2002 May; 86(10):1551-4. PubMed ID: 12085203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difluorodeoxyuridine plasma concentrations after low-dose gemcitabine during chemoradiation in head and neck cancer patients.
    Specenier P; Guetens G; Dyck J; De Boeck G; Weyler J; Van den Weyngaert D; Aelbrecht K; Vermorken JB
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):185-91. PubMed ID: 20882386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer.
    Sangar VK; McBain CA; Lyons J; Ramani VA; Logue JP; Wylie JP; Clarke NW; Cowan RA
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):420-5. PubMed ID: 15667962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine concurrent with radiation therapy for locally advanced head and neck carcinomas.
    Chauhan A; Singh H; Sharma T; Manocha KK
    Afr Health Sci; 2008 Sep; 8(3):149-55. PubMed ID: 19357741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity.
    Talamonti MS; Catalano PJ; Vaughn DJ; Whittington R; Beauchamp RD; Berlin J; Benson AB
    J Clin Oncol; 2000 Oct; 18(19):3384-9. PubMed ID: 11013279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer.
    Cengiz M; Zorlu F; Yalcin S; Gurkaynak M; Atahan IL; Gullu IH
    Med Oncol; 2007; 24(2):239-43. PubMed ID: 17848750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck.
    Aguilar-Ponce J; Granados-García M; Villavicencio V; Poitevin-Chacón A; Green D; Dueñas-González A; Herrera-Gómez A; Luna-Ortiz K; Alvarado A; Martínez-Said H; Castillo-Henkel C; Segura-Pacheco B; De la Garza J
    Ann Oncol; 2004 Feb; 15(2):301-6. PubMed ID: 14760126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy.
    Herman JM; Smith DC; Montie J; Hayman JA; Sullivan MA; Kent E; Griffith KA; Esper P; Sandler HM
    Urology; 2004 Jul; 64(1):69-73. PubMed ID: 15245938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
    Crane CH; Abbruzzese JL; Evans DB; Wolff RA; Ballo MT; Delclos M; Milas L; Mason K; Charnsangavej C; Pisters PW; Lee JE; Lenzi R; Vauthey JN; Wong AB; Phan T; Nguyen Q; Janjan NA
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1293-302. PubMed ID: 11955742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly gemcitabine and cisplatin in combination with radiotherapy in patients with locally advanced head-and-neck cancer: Phase I study.
    Viani GA; Afonso SL; Tavares VC; da Silva LG; Stefano EJ
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e231-5. PubMed ID: 21570216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.
    Vanderveken OM; Szturz P; Specenier P; Merlano MC; Benasso M; Van Gestel D; Wouters K; Van Laer C; Van den Weyngaert D; Peeters M; Vermorken J
    Oncologist; 2016 Jan; 21(1):59-71. PubMed ID: 26712958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.
    Brade A; Brierley J; Oza A; Gallinger S; Cummings B; Maclean M; Pond GR; Hedley D; Wong S; Townsley C; Brezden-Masley C; Moore M
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1027-36. PubMed ID: 17197132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer.
    Yavuz AA; Aydin F; Yavuz MN; Ilis E; Ozdemir F
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):974-81. PubMed ID: 11704320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.